Another novel finding uncovered in this study is while PLD inhibitors affected the functionality of non-tumor associated neutrophils (peripheral blood PMN), they did not inhibit peritoneal macrophages, indicating that at least some part of the innate immune system is still operative even in the presence of effective tumor-decreasing PLD inhibitors. Here, GPLD1 is linked to neoplasm.